Showing 2191-2200 of 2892 results for "".
- Allergan's New Philanthropic Program Will Benefit Kids with Upper Limb Spasticityhttps://modernaesthetics.com/news/allergans-new-philanthropic-program-will-benefit-kids-with-upper-limb-spasticity/2472879/Allergan is launching the Be The Difference philanthropic program to support children and their families who may benefit from treatment with Botox (onabotulinumtoxinA) for pediatric upper limb spasticity. Botox is approved to treat increased muscle stiffness in children 2 to 17 years of
- SkinMedica's DiamondGlow Hits Doctor's Officeshttps://modernaesthetics.com/news/skinmedicas-diamondglow-hits-doctors-offices/2472875/llergan’s Skinmedica is rolling out DiamondGlow, a non-invasive dermabrasion technology that exfoliates, extracts, and treats the face, eye area, lips and body. Allergan acquired Envy Medical, Inc and its Silkpeel&nbs
- From Baby Botox to Daddy Do-Overs, the Aesthetic Society Predicts the Hottest Trends for 2020https://modernaesthetics.com/news/from-baby-botox-to-daddy-do-overs-the-aesthetic-society-predicts-the-hottest-trends-for-2020/2472873/The Aesthetic Society predicts that 2020 will usher in the return of the facelift and the rise of the daddy do-over, i.e the male counterpart to t
- Cynosure News: Todd Tillemans Named New CEOhttps://modernaesthetics.com/news/cynosure-news-todd-tillemans-named-new-ceo/2472869/Todd Tillemans is the new Chief Executive Officer of Cynosure, LLC. Mr. Tillemans is the former President of Hershey's flagship U.S. business generating more than $6.5 billion in annual sales. Prior to that, he held various leadership positions across Unilever's
- Credentials Over Cost: AAFPRS Issues Warning to Consumers about Discount Cosmetic Treatmentshttps://modernaesthetics.com/news/credentials-over-cost-aafprs-issues-warning-to-consumers-about-discount-cosmetic-treatments/2472867/When promoting your practice, remind potential patients about your credentials and why they must choose a doctor based on his/her training and experience and not simply the best price. The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) has issued a war
- Will Fat-freezing Ice Slurries Be the Next Big Thing in Body Contouring?https://modernaesthetics.com/news/will-fat-freezing-ice-slurries-be-the-next-big-thing-in-body-contouring/2472865/An injectable ice “slurry” may selectively reduce unwanted fat, according to research in pigs published in Plastic & Reconst
- Revian: USPTO Grants Patent for Biostimulatory Approachhttps://modernaesthetics.com/news/regina-uspto-grants-patent-for-biostimulatory-approach/2472862/The United States Patent and Trademark Office (USPTO) has awarded to Revian Inc. U.S. Patent No. 10,265,258—the seminal patent on the use of proprietary color combinations of light to regenerate living tissue in the body. The claims in this issued patent cover the use
- BTL Files Patent Infringement Lawsuit Against Allergan and Zimmer Related to Emsculpthttps://modernaesthetics.com/news/btl-files-patent-infringement-lawsuit-against-allergan-and-zimmer-related-to-emsculpt/2472855/BTL Aesthetics' US affiliate has filed a lawsuit against Allergan plc, Ireland and its affiliates, and Zimmer MedizinSysteme GmbH, Germany, and its affiliate, in the US Federal District Court for the District of Delaware. The lawsuit asserts
- Alastin Skincare Receives Third Patenthttps://modernaesthetics.com/news/elastin-skincare-receives-third-patent/2472853/Alastin Skincare, Inc. has received a third US Patent from the United States Patent and Trademark Office. The patent covers Alastin’s innovative science and products. US Patent No. 10,493,011 is entitled, "Peptide Compositions and Methods for Ameliorating Skin Laxity and Bod
- Revance's DAXI Now One Step Closer to FDA Nodhttps://modernaesthetics.com/news/revances-daxi-now-one-step-closer-to-fda-nod/2472849/Revance Therapeutics, Inc. has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for DaxibotulinumtoxinA for Injection (DAXI) in the treatment of moderate to severe glabellar lines. Under